ABBV Nov 2023 175.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:49AM EDT. Market open.
| Previous close | 0.2200 |
| Open | 0.0700 |
| Bid | 0.0400 |
| Ask | 0.1200 |
| Strike | 175.00 |
| Expiry date | 2023-11-17 |
| Day's range | 0.0700 - 0.0900 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.51k |
ZacksPharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
ZacksAbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksThe Zacks Analyst Blog Highlights Oracle, AbbVie, Lowe's Companies, Ecolab and Motorola Solutions
Oracle, AbbVie, Lowe's Companies, Ecolab and Motorola Solutions are part of the Zacks top Analyst Blog .
© 2023 Yahoo. All rights reserved.
